Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy
- 12 December 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 156 (2), 320-328
- https://doi.org/10.1111/j.1365-2133.2006.07616.x
Abstract
Background Organ transplant recipients (OTR) are at high risk of developing nonmelanoma skin cancer and premalignant epidermal dysplasia (carcinoma in situ/ Bowen's disease and actinic keratoses). Epidermal dysplasia is often widespread and there are few comparative studies of available treatments. Objectives To compare topical methylaminolaevulinate (MAL) photodynamic therapy (PDT) with topical 5% fluorouracil (5‐FU) cream in the treatment of post‐transplant epidermal dysplasia. Methods Eight OTRs with epidermal dysplasia were recruited to an open‐label, single‐centre, randomized, intrapatient comparative study. Treatment with two cycles of topical MAL PDT 1 week apart was randomly assigned to one area of epidermal dysplasia, and 5‐FU cream was applied twice daily for 3 weeks to a clinically and histologically comparable area. Patients were reviewed at 1, 3 and 6 months after treatment. The main outcome measures were complete resolution rate (CRR), overall reduction in lesional area, treatment‐associated pain and erythema, cosmetic outcome and global patient preference. Results At all time points evaluated after completion of treatment, PDT was more effective than 5‐FU in achieving complete resolution: eight of nine lesional areas cleared with PDT (CRR 89%, 95% CI: 0·52–0·99), compared with one of nine lesional areas treated with 5‐FU (CRR 11%, 95% CI: 0·003–0·48) (P = 0·02). The mean lesional area reduction was also proportionately greater with PDT than with 5‐FU (100% vs. 79% respectively). Cosmetic outcome and patient preference were also superior in the PDT‐treated group. Conclusions Compared with topical 5‐FU, MAL PDT was a more effective and cosmetically acceptable treatment for epidermal dysplasia in OTRs and was preferred by patients. Further studies are now required to confirm these results and to examine the effect of treating epidermal dysplasia with PDT on subsequent development of squamous cell carcinoma in this high risk population.Keywords
This publication has 51 references indexed in Scilit:
- 5-Aminolevulinic Acid, but not 5-Aminolevulinic Acid Esters, is Transported into Adenocarcinoma Cells by System BETA TransportersPhotochemistry and Photobiology, 2007
- Photodynamic Therapy does not Prevent Cutaneous Squamous-Cell Carcinoma in Organ-Transplant Recipients: Results of a Randomized-Controlled TrialJournal of Investigative Dermatology, 2006
- Azathioprine and UVA Light Generate Mutagenic Oxidative DNA DamageScience, 2005
- Multiple Large-Surface Photodynamic Therapy Sessions with Topical or Systemic Aminolevulinic Acid and Blue Light in UV-Exposed Hairless MiceJournal of Cutaneous Medicine and Surgery, 2004
- Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipientsTransplantation, 2004
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- DNA Alkylation by 4,5-Dioxovaleric Acid, the Final Oxidation Product of 5-Aminolevulinic AcidChemical Research in Toxicology, 1998
- Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's diseaseBritish Journal of Dermatology, 1996
- Weekly pulse dosing: Effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratosesJournal of the American Academy of Dermatology, 1991